Between ASIC raids (that came to nought), the resultant resignation from his chairmanship of Creso Pharma and all manner of public scrutiny, Sydney stockbroker Adam Blumenthal (of Everblu Capital) has had a difficult few years.
But don’t feel bad for the guy. If all goes to plan, he’ll make millions flipping luxury properties in Sydney’s leafiest locales. At least, that’s the plan.
Loading...
Myriam Robin is a senior writer based in the Melbourne newsroom. She has previously been a Rear Window columnist and editor, and before that reported on financial markets and media. Connect with Myriam on Twitter. Email Myriam at myriam.robin@afr.com
